Gain and loss of function studies in mice have shown a role of FBXO32 in muscle atrophy, pathological cardiac hypertrophy, and cardiomyopathy due to premature cardiac aging34,35,38–40. Here, FBXO32 is linked to cardiac hypertrophy.